A prospective multicenter trial of S-1 with lafutidine vs S-1 as adjuvant chemotherapy for gastric cancer in Japan: AEOLUS

被引：1
|
作者：
Machida, Nozomu
Terashima, Masanori
Taku, Keisei
Daimon, Takashi
Kimura, Masashi
Sugimoto, Akihisa
Sugimoto, Akihisa
Yasui, Hirofumi
Nozaki, Isao
Fukushima, Norimasa
Takagane, Akinori
Kim, Yongil
Takiguchi, Nobuhiro
Takagi, Masakazu
Misawa, Kazunari
Kimura, Taisei
Maeda, Masato
Kanai, Toshikazu
Ota, Mitsuhiko
Yokoyama, Hidetarou
机构：
[1] Shizuoka Gen Hosp Canc Ctr, Shizuoka, Japan
[2] Shizuoka Prefectural Gen Hosp, Shizuoka, Japan
[3] Hyogo Coll Med, Nishinomiya, Hyogo, Japan
[4] Shizuoka Ind Fdn Pharma Valley Ctr, Shizuoka, Japan
[5] Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[6] Yamagata Prefectural Cent Hosp, Yamagata, Japan
[7] Hakodate Goryokaku Hosp, Hakodate, Hokkaido, Japan
[8] Seirei Hamamatsu Gen Hosp, Shizuoka, Japan
[9] Chiba Canc Ctr, Chiba, Japan
[10] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[11] Seireimikatahara Gen Hosp, Shizuoka, Japan
[12] Hamamatsu Med Ctr, Shizuoka, Japan
[13] Natl Hosp Org Kyushu Canc Ctr, Fukuoka, Japan
[14] Fujieda Municipal Gen Hosp, Shizuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.91
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
91
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase III randomized study of neoadjuvant chemotherapy (CT) with docetaxel(D), oxaliplatin(O) and S-1(S) (DOS) followed by surgery and adjuvant S-1, vs surgery and adjuvant S-1, for resectable advanced gastric cancer (GC) (PRODIGY)
    Kang, Y-K.
    Yook, J. H.
    Park, Y-K.
    Kim, Y-W.
    Kim, J.
    Ryu, M-H.
    Rha, S. Y.
    Chung, I-J.
    Kim, I-H.
    Oh, S. C.
    Yoo, C-H.
    Choi, J-H.
    Zang, D. Y.
    Kim, G.
    Lee, Y.
    Noh, S-H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [32] Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial)
    Lee, Keun-Wook
    Chung, Ik-Joo
    Ryu, Min-Hee
    Park, Young Iee
    Nam, Byung-Ho
    Oh, Ho-Suk
    Lee, Kyung Hee
    Han, Hye Sook
    Seo, Bong-Gun
    Jo, Jae-Cheol
    Lee, Hyo Rak
    Kim, Jin Won
    Park, Sook Ryun
    Cho, Sang Hee
    Kang, Yoon-Koo
    GASTRIC CANCER, 2021, 24 (01) : 156 - 167
  • [33] Systemic chemotherapy for gastric cancer with early recurrence after adjuvant S-1 monotherapy: a multicenter retrospective study
    Mitani, Seiichiro
    Kadowaki, Shigenori
    Hasegawa, Hiroko
    Wakatsuki, Takeru
    Hara, Hiroki
    Tajika, Masahiro
    Nishikawa, Kazuhiro
    Hirao, Motohiro
    Takahari, Daisuke
    Chin, Keisho
    Muro, Kei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (10) : 1197 - 1203
  • [34] Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial)
    Keun-Wook Lee
    Ik-Joo Chung
    Min-Hee Ryu
    Young Iee Park
    Byung-Ho Nam
    Ho-Suk Oh
    Kyung Hee Lee
    Hye Sook Han
    Bong-Gun Seo
    Jae-Cheol Jo
    Hyo Rak Lee
    Jin Won Kim
    Sook Ryun Park
    Sang Hee Cho
    Yoon-Koo Kang
    Gastric Cancer, 2021, 24 : 156 - 167
  • [35] Systemic chemotherapy for gastric cancer with early recurrence after adjuvant S-1 monotherapy: a multicenter retrospective study
    Seiichiro Mitani
    Shigenori Kadowaki
    Hiroko Hasegawa
    Takeru Wakatsuki
    Hiroki Hara
    Masahiro Tajika
    Kazuhiro Nishikawa
    Motohiro Hirao
    Daisuke Takahari
    Keisho Chin
    Kei Muro
    International Journal of Clinical Oncology, 2019, 24 : 1197 - 1203
  • [36] Effect of duration of adjuvant chemotherapy with S-1 (6 versus 12 months) for resected pancreatic cancer: the multicenter clinical randomized phase II postoperative adjuvant chemotherapy S-1 (PACS-1) trial
    Hiroto Kayashima
    Shinji Itoh
    Mototsugu Shimokawa
    Hiromitsu Hayashi
    Hiroshi Takamori
    Kengo Fukuzawa
    Mizuki Ninomiya
    Kenichiro Araki
    Yo-ichi Yamashita
    Keishi Sugimachi
    Hideaki Uchiyama
    Yuji Morine
    Tohru Utsunomiya
    Tadashi Uwagawa
    Takashi Maeda
    Hideo Baba
    Tomoharu Yoshizumi
    International Journal of Clinical Oncology, 2023, 28 : 1520 - 1529
  • [37] Effect of Concomitant Lafutidine on Adjuvant S-1 for Head and Neck Cancer: A Comparative Study
    Yoshino, Koichiro
    Okamoto, Isaku
    Sato, Hiroki
    Okada, Takuro
    Tokashiki, Kunihiko
    Kondo, Takahito
    Tsukahara, Kiyoaki
    ANTICANCER RESEARCH, 2021, 41 (12) : 6279 - 6285
  • [38] Effect of duration of adjuvant chemotherapy with S-1 (6 versus 12 months) for resected pancreatic cancer: the multicenter clinical randomized phase II postoperative adjuvant chemotherapy S-1 (PACS-1) trial
    Kayashima, Hiroto
    Itoh, Shinji
    Shimokawa, Mototsugu
    Hayashi, Hiromitsu
    Takamori, Hiroshi
    Fukuzawa, Kengo
    Ninomiya, Mizuki
    Araki, Kenichiro
    Yamashita, Yo-ichi
    Sugimachi, Keishi
    Uchiyama, Hideaki
    Morine, Yuji
    Utsunomiya, Tohru
    Uwagawa, Tadashi
    Maeda, Takashi
    Baba, Hideo
    Yoshizumi, Tomoharu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (11) : 1520 - 1529
  • [39] Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
    Akinori Hisashige
    Mitsuru Sasako
    Toshifusa Nakajima
    BMC Cancer, 13
  • [40] S-1: changing the facets of adjuvant chemotherapy in pancreatic cancer?
    Perkhofer, Lukas
    Ettrich, Thomas J.
    Kleger, Alexander
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S898 - S902
12345